Contents

Part 1: Performance Plan Summary

Introduction
Part One: An Overview
Part Two: Highlights of FY 2001 Accomplishments
Part Three: FDA Strategic Goals, FY 2002 and 2003 Performance Goals, and FY 2001 Performance Accomplishments
     Strategic Goals:
     Countering the Terrorist Threat
     Maintaining a Strong and Effective FDA
     Assuring Medical Product Safety
     Bringing New Technologies to a World Wide Market
Part Four: Partnerships and Coordination

Part 2: Performance Plan and Report

Introduction
2.1 Administrative Management
2.2 Foods
2.3 Human Drugs
2.4 Biologics
2.5 Animal Drugs and Feeds
2.6 Medical Devices and Radiological Health
2.7 National Center for Toxicological Research

Appendix

Appendix A--Glossary of Acronyms
Appendix B--Disposition Table

For a printed copy of this report, contact:
Office of Planning (HFP-20)
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857

Office of Planning Home Page
FDA Home Page | Search | A-Z Index | Site Map | Contact FDA

FDA/Office of Planning
Web page created by clb 2002-FEB-07.